Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc — Grants Pass, Oregon

Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc is a clinical research site located in Grants Pass, Oregon, United States 97527.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis.

Sponsors: Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc?

Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc conducted?

Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc has 1 clinical trials on record. Their work covers Atopic Dermatitis.

Is Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc accredited by Crixeo Health?

Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.